Citations for
1CD40, TNFSF12, TRAF2
TWEAK inhibits TRAF2-mediated CD40 signaling by destabilization of CD40 signaling complexes.
Salzmann S, Lang I, Rosenthal A, Schäfer V, Weisenberger D, Carmona Arana JA, Trebing J, Siegmund D, Neumann M, Wajant H.
J Immunol 191(5):2308-18. doi: 10.4049/jimmunol.1202899. Epub 2013 Aug 5. 2013
2BIRC3, NFKB1, TNFSF12
TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway.
Enwere EK, Holbrook J, Lejmi-Mrad R, Vineham J, Timusk K, Sivaraj B, Isaac M, Uehling D, Al-awar R, LaCasse E, Korneluk RG.
Sci Signal 5(246):ra75. doi: 10.1126/scisignal.2003086. 2012
3TNF, TNFSF12
The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB.
Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez-Larrea C, Jakubowski A, Blanco J, Ramirez R, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A, Sanz AB.
J Am Soc Nephrol 22(7):1315-25. Epub 2011 Jun 30. 2011
4TNFRSF12A, TNFSF12
Full-length, membrane-anchored TWEAK can function as a juxtacrine signaling molecule and activate the NF-kappaB pathway.
Brown SA, Ghosh A, Winkles JA.
J Biol Chem 285(23):17432-41. Epub 2010 Apr 12.PMID: 20385556 2010
5TNFRSF12A, TNFSF12
Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.
Ebihara N, Nakayama M, Tokura T, Iwatsu M, Ushio H, Murakami A.
Curr Eye Res 34(10):836-44.PMID: 19895311 2009
6TNFSF12
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C.
Arthritis Res Ther 11(5):R143. Epub 2009 Sep 28.PMID: 19785730 2009
7TNFSF12
Considering TWEAK as a target for therapy in renal and vascular injury.
Ortiz A, Sanz AB, Muñoz García B, Moreno JA, Sánchez Niño MD, Martín-Ventura JL, Egido J, Blanco-Colio LM.
Cytokine Growth Factor Rev 20(3):251-8. Epub 2009 May 30. Review.PMID: 19482507 2009
8TNFRSF12A, TNFSF12
TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression.
Dai L, Gu L, Ding C, Qiu L, Di W.
Cancer Lett 283(2):159-67. Epub 2009 Apr 23.PMID: 19398263 2009
9TNFRSF12A, TNFSF12
A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.
Jain M, Jakubowski A, Cui L, Shi J, Su L, Bauer M, Guan J, Lim CC, Naito Y, Thompson JS, Sam F, Ambrose C, Parr M, Crowell T, Lincecum JM, Wang MZ, Hsu YM, Zheng TS, Michaelson JS, Liao R, Burkly LC.
Circulation 119(15):2058-68. Epub 2009 Apr 6.PMID: 19349318 2009
10TNFSF12
Soluble TWEAK is markedly elevated in hemophagocytic lymphohistiocytosis.
Nagasawa M, Yi Z, Imashuku S, Nonoyama S, Ogawa K, Okumura K, Mizutani S.
Am J Hematol 83(3):222-5.PMID: 17918252 2008
11TNFRSF12A, TNFSF12
Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis.
Dogra C, Hall SL, Wedhas N, Linkhart TA, Kumar A.
J Biol Chem 282(20):15000-10. Epub 2007 Mar 22. 2007
12TNFRSF12A, TNFSF12
Age-dependent effects of TWEAK/Fn14 receptor activation on neural progenitor cells.
Hamill CA, Michaelson JS, Hahm K, Burkly LC, Kessler JA.
J Neurosci Res 85(16):3535-44.PMID: 17803219 2007
13TNFRSF12A, TNFSF12
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration.
Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS.
EMBO J 25(24):5826-39. Epub 2006 Nov 23. 2006
14TNFSF12, TNFRSF12A
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL, McDonough WS, Savitch BA, Sawyer TF, Winkles JA, Berens ME.
J Biol Chem 280(5):3483-92. Epub 2004 Dec 16. 2005
15TNFSF12
TWEAK attenuates the transition from innate to adaptive immunity.
Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, Yang B, Daniel D, Ashkenazi A.
Cell 123(5):931-44. 2005
16TNFSF12
Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis.
Kawakita T, Shiraki K, Yamanaka Y, Yamaguchi Y, Saitou Y, Enokimura N, Yamamoto N, Okano H, Sugimoto K, Murata K, Nakano T.
Biochem Biophys Res Commun 318(3):726-33. 2004
17TNFRSF12A , TNFSF12
TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T.
J Biol Chem 278(34):32317-23. Epub 2003 Jun 6. 2003
18ALOX12, ATP1B2, CD68, CHD3, CHRNB1, EIF4A1, FGF11, FXR2, GUCY2D, KDM6B, NEUROD2, SHBG, TNFSF12, TNFSF13, TP53
Physical Map of 17p13 and the Genes Adjacent to p53.
Cousin P, Billotte J, Chaubert P, Shaw P.
Genomics 63(1):60-68. 2000
19TNFSF12
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis.
Chicheportiche Y, et al.
J Biol Chem 272 : 32401-32410. 1997